HK1203377A1 - Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent - Google Patents

Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Info

Publication number
HK1203377A1
HK1203377A1 HK15103952.3A HK15103952A HK1203377A1 HK 1203377 A1 HK1203377 A1 HK 1203377A1 HK 15103952 A HK15103952 A HK 15103952A HK 1203377 A1 HK1203377 A1 HK 1203377A1
Authority
HK
Hong Kong
Prior art keywords
treatment
chemically modified
heparan sulphate
modified heparin
postpartum haemorrhage
Prior art date
Application number
HK15103952.3A
Other languages
English (en)
Chinese (zh)
Inventor
‧埃克曼-奧德貝格
‧馬爾姆斯特倫
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of HK1203377A1 publication Critical patent/HK1203377A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15103952.3A 2012-05-08 2015-04-23 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent HK1203377A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261644036P 2012-05-08 2012-05-08
US201261668150P 2012-07-05 2012-07-05
PCT/SE2013/050510 WO2013169194A1 (en) 2012-05-08 2013-05-07 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Publications (1)

Publication Number Publication Date
HK1203377A1 true HK1203377A1 (en) 2015-10-30

Family

ID=49551063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103952.3A HK1203377A1 (en) 2012-05-08 2015-04-23 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Country Status (16)

Country Link
US (1) US20150099703A1 (de)
EP (1) EP2846810A4 (de)
JP (1) JP2015516415A (de)
CN (1) CN104284667A (de)
AU (1) AU2013260209A1 (de)
BR (1) BR112014027712B1 (de)
CA (1) CA2868403A1 (de)
HK (1) HK1203377A1 (de)
IL (1) IL234752A0 (de)
MX (1) MX2014013449A (de)
MY (1) MY192330A (de)
NZ (1) NZ701419A (de)
RU (1) RU2014149230A (de)
SG (1) SG11201407346WA (de)
UA (1) UA117912C2 (de)
WO (1) WO2013169194A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4106765A1 (de) 2020-02-17 2022-12-28 Dilafor AB Tafoxiparin zur behandlung von präeklampsie
EP4272749A1 (de) 2022-05-03 2023-11-08 Dilafor AB Neue medizinische verwendung von tafoxiparin
TW202406559A (zh) 2022-05-03 2024-02-16 瑞典商迪拉佛公司 塔夫西肝素(tafoxiparin)之新穎醫藥用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
UA21707U (en) * 2006-12-18 2007-03-15 Valerii Ivanovych Linnikov Method for preventing and treating thrombophilia in course of gestation and postpartum
WO2009073184A1 (en) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
RU2617764C2 (ru) * 2011-12-19 2017-04-26 Дилафор Аб Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
AU2013240597A1 (en) * 2012-03-26 2014-10-16 Dilafor Ab Combination treatment comprising sulphated glycosaminoglycans for inducing labor
JP2015514705A (ja) * 2012-03-26 2015-05-21 ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ 分娩停止の処置のための方法

Also Published As

Publication number Publication date
WO2013169194A1 (en) 2013-11-14
AU2013260209A1 (en) 2014-11-20
MX2014013449A (es) 2014-12-08
EP2846810A4 (de) 2016-04-13
US20150099703A1 (en) 2015-04-09
BR112014027712B1 (pt) 2023-12-19
CA2868403A1 (en) 2013-11-14
MY192330A (en) 2022-08-17
NZ701419A (en) 2016-04-29
JP2015516415A (ja) 2015-06-11
UA117912C2 (uk) 2018-10-25
EP2846810A1 (de) 2015-03-18
BR112014027712A2 (pt) 2017-06-27
CN104284667A (zh) 2015-01-14
RU2014149230A (ru) 2016-06-27
SG11201407346WA (en) 2014-12-30
IL234752A0 (en) 2014-11-30

Similar Documents

Publication Publication Date Title
IL240775B (en) Anti-occlusion fluoroscopy-independent balloon-guided catheter and methods of use
HK1220339A1 (zh) 組織和血管閉合裝置及其使用方法
EP2928537A4 (de) Ballonkatheter und verfahren zur verwendung davon
IL240862A0 (en) Intra-arterial access systems and methods of use
EP2804036A4 (de) Endoskopspitzenkomponente und endoskop
PL3011090T3 (pl) Włókna polisacharydowe o dużej chłonności i ich zastosowanie
EP2994173A4 (de) Wundheilung und gewebeaufbau
EP2879617A4 (de) Vorrichtungen und verfahren zur behandlung von augenarterienokklusion
EP2825363A4 (de) Flexibler medizinischer artikel und verfahren zur herstellung davon
EP2934647A4 (de) Distalkatheterspitzen und formung davon
SG11201401971VA (en) Absorbent Body and Absorbent Article Comprising Absorbent Body
SG10202112138QA (en) Compositions comprising peg and sulphate
EP2974751A4 (de) Herz- oder gefässgewebe-sphäroid
EP2863813A4 (de) Biologisch abbaubare blutgefässokklusion und -verengung
HK1209031A1 (en) Polysaccharide compositions and methods of use
IL228284A (en) Implants from cellular scaffolding and blood vessel stalk
PL2814770T3 (pl) Segment przegubowego ramienia i przegubowe ramię zawierające wspomniany segment
HK1221906A1 (zh) 硫酸乙酰肝素
HK1214958A1 (zh) 凝血酶溶液及其使用方法
IL233875A0 (en) A preparation and its use for the treatment of anal fissures
HK1203377A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
EP2815760A4 (de) Mittel zur verhinderung oder linderung einer vaskulären endothelialen fehlfunktion
PL2714894T3 (pl) Systemy biosztucznych kanalików proksymalnych oraz sposoby ich stosowania
EP2981556A4 (de) Ethylsulfonierte hyaluronsäurebiopolymere und verfahren zur verwendung davon
EP2968730A4 (de) Okklusionsresistenter katheter und verfahren zur verwendung